Level Bio
Logotype for Level Bio

Level Bio (LEVBIO) investor relations material

Level Bio Q4 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Level Bio
Q4 2025 earnings summary19 Feb, 2026

Executive summary

  • Achieved 29% year-over-year revenue growth to 32,361 KSEK for 2025, with Q4 revenue up 26% to 9,422 KSEK compared to the same quarter last year.

  • Sold subsidiary CyberGene AB to Devyser AB for 12.2 MSEK in early 2026, resulting in a capital gain of 7–8 MSEK and a strategic focus on core distribution business.

  • Positive cash flow throughout 2025, with improved operating results and a strengthened balance sheet supporting future expansion.

Financial highlights

  • Full-year net sales: 32,361 KSEK (up 29% from 25,096 KSEK in 2024); Q4 net sales: 9,422 KSEK (up 26%).

  • Gross margin for 2025 was 53% (down from 54% in 2024); Q4 gross margin at 52% (down from 58%).

  • Operating result (EBIT) for 2025: -3,487 KSEK (improved from -8,083 KSEK); Q4 EBIT: -888 KSEK (improved from -1,479 KSEK).

  • Net result after tax for 2025: -3,539 KSEK (improved from -7,872 KSEK); Q4 net result: -1,093 KSEK.

  • Cash flow for 2025: 1,406 KSEK (up from -2,551 KSEK); cash and cash equivalents at year-end: 2,485 KSEK.

Outlook and guidance

  • Focus shifts to Nordic distribution of molecular biology lab products via Techtum Lab after CyberGene divestment.

  • Anticipates a ~15% reduction in consolidated revenue and lower gross margin from Q2 2026 due to CyberGene sale.

  • Plans for continued expansion in the Nordics, leveraging a strengthened balance sheet and innovative product portfolio.

Explain the significant solvency drop
CyberGene divestment: strategic rationale
Techtum Lab's Nordic expansion strategy
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Level Bio earnings date

Logotype for Level Bio
Q1 202623 Apr, 2026
Level Bio
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Level Bio earnings date

Logotype for Level Bio
Q1 202623 Apr, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Level Bio is a biotechnology company focused on the development of innovative solutions in the life sciences sector. The company engages in research and product development aimed at addressing challenges in healthcare, leveraging advanced technologies and scientific expertise. Level Bio serves industries such as pharmaceuticals, diagnostics, and medical research with applications designed to improve patient care and treatment outcomes. The company is headquartered in Lund, Sweden, and its shares are listed on the Spotlight Stock Market.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage